# Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer

> **NCT07531329** · — · RECRUITING · sponsor: **Xijing Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Treatment-naive Prostate Cancer
- Suspected Prostate Cancer
- Molecular Imaging

## Interventions

- **DIAGNOSTIC_TEST:** [⁶⁸Ga]Ga-PSMA PET/CT with Delayed Pelvic PET-Only Acquisition

## Key facts

- **NCT ID:** NCT07531329
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-05
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-03-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07531329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07531329, "Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07531329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*